• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内皮细胞中雌激素受体α和雌激素受体β对纤溶酶原激活物抑制剂-1(PAI-1)启动子活性的差异及相反调节作用

Differential and opposing regulation of PAI-1 promoter activity by estrogen receptor alpha and estrogen receptor beta in endothelial cells.

作者信息

Smith Layton Harris, Coats Stephen R, Qin Hao, Petrie Matthew S, Covington Joseph W, Su Ming, Eren Mesut, Vaughan Douglas E

机构信息

Department of Medicine, Vanderbilt University Medical Center and Nashville Veterans Affairs Medical Center, Nashville, Tenn 37232-6300, USA.

出版信息

Circ Res. 2004 Aug 6;95(3):269-75. doi: 10.1161/01.RES.0000136521.70093.f1. Epub 2004 Jun 24.

DOI:10.1161/01.RES.0000136521.70093.f1
PMID:15217907
Abstract

To investigate the molecular mechanisms involved in the estrogen-dependent control of plasminogen activator inhibitor-1 (PAI-1) gene expression in vascular cells, we compared the transactivation properties of estrogen receptors (ERalpha and ERbeta) in regulating the activity of a human PAI-1 promoter reporter construct in transfected bovine aortic endothelial cells (BAECs). ERalpha increased PAI-1 promoter activity in BAECs by an estrogen-dependent mechanism, whereas ERbeta suppressed PAI-1 promoter activity by an estrogen-independent mechanism. The suppressive activity of ERbeta was dominant over the inductive activity of ERalpha. Mutation of a putative estrogen response element (ERE) located at position -427 in the proximal promoter abolished the ERalpha action without influencing the suppressive effects of ERbeta. Mutation of either AP1-like site did not eliminate the ERalpha or ERbeta actions at the PAI-1 promoter, suggesting that other promoter elements are involved in these responses. These mutations significantly reduced the -3.4kbp PAI-1 promoter response to serum. We concluded that ERalpha and ERbeta exert differential effects on the PAI-1 promoter activity in transfected BAECs. ERalpha activated the PAI-1 promoter through a proximal ERE (-427) and possibly additional EREs located within the PAI-1 promoter, whereas ERbeta suppressed the promoter construct via an unidentified mechanism. This is the first demonstration of the differential regulation of a vascular gene promoter by ERalpha and ERbeta.

摘要

为了研究血管细胞中纤溶酶原激活物抑制剂-1(PAI-1)基因表达的雌激素依赖性调控所涉及的分子机制,我们比较了雌激素受体(ERα和ERβ)在转染的牛主动脉内皮细胞(BAECs)中调节人PAI-1启动子报告基因构建体活性的反式激活特性。ERα通过雌激素依赖性机制增加BAECs中PAI-1启动子活性,而ERβ通过雌激素非依赖性机制抑制PAI-1启动子活性。ERβ的抑制活性强于ERα的诱导活性。位于近端启动子-427位的假定雌激素反应元件(ERE)发生突变消除了ERα的作用,而不影响ERβ的抑制作用。任一AP1样位点发生突变均未消除ERα或ERβ在PAI-1启动子上的作用,提示其他启动子元件参与了这些反应。这些突变显著降低了-3.4kbp PAI-1启动子对血清的反应。我们得出结论,ERα和ERβ对转染的BAECs中PAI-1启动子活性具有不同的影响。ERα通过近端ERE(-427)以及可能位于PAI-1启动子内的其他ERE激活PAI-1启动子,而ERβ通过未知机制抑制启动子构建体。这是首次证明ERα和ERβ对血管基因启动子的差异调节。

相似文献

1
Differential and opposing regulation of PAI-1 promoter activity by estrogen receptor alpha and estrogen receptor beta in endothelial cells.内皮细胞中雌激素受体α和雌激素受体β对纤溶酶原激活物抑制剂-1(PAI-1)启动子活性的差异及相反调节作用
Circ Res. 2004 Aug 6;95(3):269-75. doi: 10.1161/01.RES.0000136521.70093.f1. Epub 2004 Jun 24.
2
Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.雌二醇和他莫昔芬对乳腺癌细胞中血管内皮生长因子的转录调控:雌激素受体α和β之间的复杂相互作用
Cancer Res. 2002 Sep 1;62(17):4977-84.
3
A new slice of pie? Estrogen regulation of plasminogen activator inhibitor-1.
Circ Res. 2004 Aug 6;95(3):228-9. doi: 10.1161/01.RES.0000139435.06532.cf.
4
Molecular basis of estrogen-induced cyclooxygenase type 1 upregulation in endothelial cells.雌激素诱导内皮细胞中环氧合酶-1上调的分子基础
Circ Res. 2005 Mar 18;96(5):518-25. doi: 10.1161/01.RES.0000158967.96231.88. Epub 2005 Feb 10.
5
Transcriptional regulation of tyrosine hydroxylase by estrogen: opposite effects with estrogen receptors alpha and beta and interactions with cyclic AMP.雌激素对酪氨酸羟化酶的转录调控:雌激素受体α和β的相反作用以及与环磷酸腺苷的相互作用
J Neurochem. 2005 Jun;93(6):1502-14. doi: 10.1111/j.1471-4159.2005.03142.x.
6
Tamoxifen induces the expression of maspin through estrogen receptor-alpha.他莫昔芬通过雌激素受体α诱导maspin的表达。
Cancer Lett. 2004 Jun 8;209(1):55-65. doi: 10.1016/j.canlet.2003.11.018.
7
Identification of two functional estrogen response elements complexed with AP-1-like sites in the human insulin receptor gene promoter.在人胰岛素受体基因启动子中鉴定出两个与AP-1样位点复合的功能性雌激素反应元件。
J Steroid Biochem Mol Biol. 2005 Feb;94(1-3):1-14. doi: 10.1016/j.jsbmb.2004.12.020. Epub 2005 Feb 3.
8
Tamoxifen agonism and estrogen antagonism of c-fos gene promoter activity through non-consensus-responsive elements in MC3T3-E1 osteoblasts.他莫昔芬通过MC3T3-E1成骨细胞中的非共识反应元件对c-fos基因启动子活性产生激动作用和雌激素拮抗作用。
Biochem Biophys Res Commun. 2001 Dec 7;289(3):705-11. doi: 10.1006/bbrc.2001.6045.
9
Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta.雌激素受体(ER)介导的人促肾上腺皮质激素释放激素结合蛋白启动子的转录调控:ERα和ERβ的不同作用
Mol Endocrinol. 2004 Dec;18(12):2908-23. doi: 10.1210/me.2003-0446. Epub 2004 Sep 2.
10
Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.雌激素受体通向雌激素反应元件的途径:反式激活功能-1作为雌激素受体(ER)β介导的ERα转录抑制的关键要素。
J Steroid Biochem Mol Biol. 2007 May;104(3-5):110-22. doi: 10.1016/j.jsbmb.2007.03.002. Epub 2007 Mar 12.

引用本文的文献

1
The 4G/5G Polymorphism of Plasminogen Activator Inhibitor Type 1 is a Predictor of Moderate-to-Severe Thyroid Eye Disease.纤溶酶原激活物抑制剂1的4G/5G多态性是中重度甲状腺眼病的一个预测指标。
J Inflamm Res. 2021 May 12;14:1883-1890. doi: 10.2147/JIR.S307046. eCollection 2021.
2
Oleuropein is a natural inhibitor of PAI-1-mediated proliferation in human ER-/PR- breast cancer cells.橄榄苦苷是一种天然的 PAI-1 介导的人 ER-/PR-乳腺癌细胞增殖抑制剂。
Breast Cancer Res Treat. 2021 Apr;186(2):305-316. doi: 10.1007/s10549-020-06054-x. Epub 2021 Jan 3.
3
Effects of 17β-Estradiol on the Plasminogen Activator System in Vascular Smooth Muscle Cells Treated with Lysophophatidylcholine.
17β-雌二醇对经溶血磷脂酰胆碱处理的血管平滑肌细胞中纤溶酶原激活系统的影响。
J Menopausal Med. 2020 Apr;26(1):9-17. doi: 10.6118/jmm.19005.
4
Combined but not single treatment with ethinylestradiol/levonorgestrel and spironolactone reduces plasminogen activator inhibitor-1 in insulin-resistant ovariectomised rats.雌二醇/左炔诺孕酮与螺内酯联合而非单独治疗可降低胰岛素抵抗去卵巢大鼠的纤溶酶原激活物抑制剂-1。
J Renin Angiotensin Aldosterone Syst. 2019 Oct-Dec;20(4):1470320319895933. doi: 10.1177/1470320319895933.
5
Improvement of Psychotic Symptoms and the Role of Tissue Plasminogen Activator.精神病症状的改善与组织型纤溶酶原激活剂的作用
Int J Mol Sci. 2015 Nov 18;16(11):27550-60. doi: 10.3390/ijms161126053.
6
Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer.在被诊断患有乳腺癌的非洲裔和高加索裔美国女性中,处于相同分期和年龄的肿瘤标本之间乳腺癌相关基因的差异表达。
BMC Res Notes. 2012 May 22;5:248. doi: 10.1186/1756-0500-5-248.
7
Increased PAI-1 in females compared with males is protective for abdominal aortic aneurysm formation in a rodent model.与男性相比,女性的 PAI-1 增加对形成腹主动脉瘤具有保护作用。
Am J Physiol Heart Circ Physiol. 2012 Apr 1;302(7):H1378-86. doi: 10.1152/ajpheart.00620.2011. Epub 2012 Feb 3.
8
Vascular effects of estrogenic menopausal hormone therapy.雌激素类绝经激素治疗的血管效应
Rev Recent Clin Trials. 2012 Feb;7(1):47-70. doi: 10.2174/157488712799363253.
9
Long-term estrogen exposure promotes carcinogen bioactivation, induces persistent changes in gene expression, and enhances the tumorigenicity of MCF-7 human breast cancer cells.长期雌激素暴露会促进致癌物的生物活化,诱导基因表达的持续变化,并增强MCF-7人乳腺癌细胞的致瘤性。
Toxicol Appl Pharmacol. 2009 Nov 1;240(3):355-66. doi: 10.1016/j.taap.2009.07.013. Epub 2009 Jul 18.
10
Estradiol increases angiotensin II type 1 receptor in hearts of ovariectomized rats.雌二醇可增加去卵巢大鼠心脏中的血管紧张素II 1型受体。
J Endocrinol. 2009 Jan;200(1):75-84. doi: 10.1677/JOE-08-0199. Epub 2008 Oct 17.